nilotinib
CHEBI:CHEBI_52172
Chemical Information
- Molecular Formula
- C28H22F3N7O
- Molecular Mass
- 529.51580
- Charge
- 0
- SMILES
- Cc1cn(cn1)-c1cc(NC(=O)c2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)cc(c1)C(F)(F)F
- InChI
- InChI=1S/C28H22F3N7O/c1-17-5-6-19(10-25(17)37-27-33-9-7-24(36-27)20-4-3-8-32-14-20)26(39)35-22-11-21(28(29,30)31)12-23(13-22)38-15-18(2)34-16-38/h3-16H,1-2H3,(H,35,39)(H,33,36,37)
- InChIKey
- HHZIURLSWUIHRB-UHFFFAOYSA-N
Alternative Names
- 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide
- AMN 107
- AMN107
- nilotinib
- nilotinib
- nilotinibum
Drug Classification
-
pyrimidinesView Class →
CHEBI:39447
-
secondary carboxamideView Class →
CHEBI:140325
-
imidazolesView Class →
CHEBI:24780
-
pyridinesView Class →
CHEBI:26421
-
secondary amino compoundView Class →
CHEBI:50995
-
(trifluoromethyl)benzenesView Class →
CHEBI:83565
-
t244731
-
t245252
-
t245330
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- core#notation
- CHEBI:52172
- DRON_00010000
- 662281
- oboInOwl#hasDbXref
- Wikipedia:Nilotinib
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- rxcui
- 2002719
- listing_expiration_date
- 20241231
- route
- ORAL
- package_marketing_start_date
- 08-JUL-22
- manufacturer_name
- Azurity Pharmaceuticals, Inc.
- active_ingredient_name
- NILOTINIB HYDROCHLORIDE DIHYDRATE
- spl_id
- 08ffad54-6e85-7c26-e063-6394a90ab472
- package_ndc
- 81955-0017-1
- package_description
- 10 kg in 1 DRUM (81955-0017-1)
- marketing_start_date
- 20151231
- unii
- F41401512X
- spl_set_id
- 6093952a-5248-45cb-ad17-33716a411146
- core#notation
- CHEBI:52172
- active_ingredient_strength
- 350 kg/350kg
- pharm_class_moa
- UGT1A1 Inhibitors [MoA]
- pharm_class
- UGT1A1 Inhibitors [MoA]
- nui
- N0000191272
- pharm_class_epc
- Kinase Inhibitor [EPC]
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- oboInOwl#hasOBONamespace
- chebi_ontology
- DRON_00010000
- 662281
- oboInOwl#hasDbXref
- Wikipedia:Nilotinib
- oboInOwl#id
- CHEBI:52172
- generic_name
- NILOTINIB HYDROCHLORIDE
- product_type
- BULK INGREDIENT
- marketing_category
- BULK INGREDIENT
- dosage_form
- CAPSULE
- labeler_name
- VALARY LAB PRIVATE LIMITED
- product_ndc
- 81955-0017
- brand_name
- Tasigna
- brand_name_base
- Tasigna
- application_number
- NDA022068
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_38637
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- has_treatment
- http://purl.obolibrary.org/obo/DOID_6367
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_side_effect28183
- owl#annotatedSource
- t245736
- owl#someValuesFrom
- t1054933